Characterization of vascular leak syndrome induced by the toxin component of Pseudomonas exotoxin-based immunotoxins and its potential inhibition with nonsteroidal anti-inflammatory drugs

Clinical Cancer Research

Volumn 3, Issue 3, 1997, Pages 339-345

  Siegall, Clay B ^a   Liggitt, Denny ^b   Chace, Dana ^a   Mixan, Bruce ^a   Sugai, James ^a   Davidson, Thomas ^c   Steinitz, Michael ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BRISTOL MYERS SQUIBB COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CARBOXYPHENYL) 3,7 DIMETHYL 9 (2,6,6 TRIMETHYL 1 CYCLOHEXENYL) 2,4,6,8 NONATETRAENOIC ACID; CIMETIDINE; CROMOGLYCATE DISODIUM; FLURBIPROFEN; IMMUNOTOXIN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPASE INHIBITOR; PIROXICAM; PSEUDOMONAS EXOTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HYDROTHORAX; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SYNDROME;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BACTERIAL TOXINS; CAPILLARY LEAK SYNDROME; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DEXAMETHASONE; EXOTOXINS; FEMALE; GENE EXPRESSION REGULATION; HYDROTHORAX; IMMUNOTOXINS; INTERLEUKIN-1; ISOENZYMES; LUNG; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; TRANSCRIPTION, GENETIC; VIRULENCE FACTORS;

EID: 0030968650     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Vitetta, E. S., Thorpe, P. E., and Uhr, J. W. Immunotoxins: magic bullets or misguided missiles? Trends. Pharmacol. Sci., 14: 148-154, 1993.
2. Frankel, A. E., Tagge, E. P., and Willingham, M. C. Clinical trials of targeted toxins. Semin. Cancer Biol., 6: 307-317, 1995.
3. Vitetta, E. S., Stone, M., Amlot. P., Fay, J., May, R., Till, M., Newman, J., Clark, P., Collins, R., Cunningham, D., Ghetie, V., Uhr, J. W., and ThoFpe, P. E. Phase I immunotoxin trial in patients with B-cell lymphoma. Cancer Res., 51: 4052-4058, 1991.
4. Sausville, E. A., De Headlee, D., Stetler-Stevenson, Jaffe, E. S., Solomon, D., Figg, W. D., Herdt, J., Kopp, W. C., Rager, H., Steinberg, S. M., Ghetie, V., Schnidler, J., Uhr. J., Wittes, R. E., and Vitetta, E. S. Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I study. Blood, 85: 3457-3465, 1995.
5. Epstein, C., Lynch, T., Shefner, J., Wen, P., Maxted, D., Braman, V., Ariniello, P., Coral, F., and Ritz, J. Use of the immunotoxin N901-blocked ricin in patients with small-cell lung cancer. Int. J. Cancer, 8: 57-59, 1994.
6. Pai, L. H., Wittes, R., Setser, A., Willingham, M. C., and Pastan. I. Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin. Nat. Med., 2: 350-353, 1996.
7. Amlot, P. L., Stone, M. J., Cunningham, D., Fay, J., Newman, J., Collins, R., May, R., McCarthy, M., Richardson, J., Ghetie, V., Ramilo, O., Thorpe, P. E., Uhr, J. W., and Vitetta, E. S. A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Blood, 82: 2624-2633, 1993.
8. Siegall, C. B., Liggitt, D., Chace, D., Tepper, M. A., and Fell, H. P. Prevention of immunotoxin-mediated vascular leak syndrome in rats with retention of antitumor activity. Proc. Natl. Acad. Sci. USA, 91: 9514-9518, 1994.
9. Kondo, T., FilzGerald, D., Chaudhary, V. K., Adhya, S., and Pastan, I. Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain. J. Biol. Chem., 263: 9470-9475, 1988.
10. Debinski, W., Karlsson, B., Lindholm, L., Siegall. C. B., Willingham, M. C., FitzGerald, D. J., and Pastan, I. Monoclonal antibody C242-Pseudomonas exotoxin A: a specific and potent immunotoxin with antitumor activity on a human colon cancer xenograft in nude mice. J. Clin. Invest., 90: 405-411, 1992.
11. Gray, G. L., Smith, O. H., Baidridge, J. S., Hoskins, R. N., Vasil, M. L., Chen, E. Y., and Hayneker, H. L. Cloning, nucleotide sequence and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA, 83: 1320-1324, 1984.
12. Collier, R. J., and Kandel, J. Structure and activity of diphtheria toxin. J. Biol. Chem., 246: 1496-1503, 1971.
13. Siegall, C. B., Chace, D., Mixan, B., Garrigues, U., Wan, H., Paul, L., Hellström, I., and Hellström, K. E. In vitro and in vivo characterization of BR96 sFv-PE40. a single-chain immunotoxin fusion protein that cures human breast carcinoma xenografts in athymic mice and rats. J. Immunol., 752: 2377-2384, 1994.
14. y-related cell-surface antigens. Cancer Res., 50: 2183-2190, 1990.
15. Nishida, T., Nishino, N., Takano, M., Sekiguchi, Y., Kawai, K., Mizuno, K., Nalai, S., Masui, Y., and Hirai, Y. Molecular cloning and expression of rat interleukin-lct cDNA. J. Biochem., 705: 351-357, 1989.
16. Carroll, S. F., and Collier, R. J. Active site of Pseudomonas aeruginosa exotoxin A glutamic acid 553 is photolabeled by NAD and shows functional homology with glutamic acid 148 of Diphtheria toxin. J. Biol. Chem., 202: 8707-8711, 1987.
17. Hwang, J., FitzGerald, D. J. P., Adhya, S., and Pastan, I. Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell, 48: 129-136, 1987.
18. Ogata, M., Chaudhary, V. K., Pastan, I., and FitzGerald, D. J. Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000 Da toxin fragment that is translocated to the cytosol. J. Biol. Chem., 205: 20678-20685, 1990.
19. 280 generates the enzymatically active fragment which translocates to the cytosol. J. Biol. Chem., 267: 25396-25401, 1992.
20. 2 with topical anti-inflammatory activity. Biochem. Biophys. Res. Commun., 189: 272-279, 1992.
21. Mitchell, J. A., Akarasereenont, Thiemermann, P. C., Flower, R. J., and Vane, J. R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA, 90: 11693-11697, 1993.
22. Ristimaki, A., Garfinkel, S., Wessendorf, J., Maciag, T., and Hla, T. Induction of cyclooxygenase-2 by interleukin-la. J. Biol. Chem., 209: 11769-11775, 1994.
23. Seibert, K., Zhang, Y., Leahy, K., Hauser, S., Masferrer, J., Perkins, W., Lee, L., and Isakson, P. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Natl. Acad. Sci. USA, 91: 12013-12017, 1994.
24. Rosenstein, M., Ettinghausen, S. E., and Rosenberg, S. A. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2, J. Immunol., 137: 1735-1742, 1986.
25. Rosenberg, S. A., Lotze, M. T., Muul, L. M., Chang, A. E., Aviis, F. P., Leitman, S., Linehan, M., Robertson, C. N., Lee, C. N., Rubion, J. T., Seipp, C. A., Simpson, C. G., and White, D. E. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N. Engl. J. Med., 316: 889-897, 1987.
26. Soler-Rodriguez, A. M., Ghetie, M. A., Oppenheimer-Marks, N., Uhr, J. W., and Vitetta, E. S. Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome. Exp. Cell Res., 206: 227-234, 1993.
27. Y damage human endothelial cells in an antibody-specific mode: relevance to vascular leak syndrome. Clin. Cancer. Res., 1: 1589-1594, 1995.
28. Masferrer, J. L., Seibert, K., Zweifel, B. S., and Needleman, P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc. Natl. Acad. Sci. USA, 59: 3917-3921, 1992.
29. Goldblum, S. E., Yoneda, K., Cohen, D. A., and McLain, C. J. Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-Iβ. Infect. Immun., 56: 2255-2263, 1988.
30. Quelux, T. T., Brunda, M., Vladutia, A. O., Brenrjens, J. R., and Andres, G. Morphological basis of pulmonary edema in mice with cytokine-induced vascular leak syndrome. Exp. Lung Res., 17: 1095-1108, 1991.
31. Dubinett, S. M., Huang, M., Lichtenstein, A., Mcbride, W. H., Wang, J., Markovitz, G., Kelley, D., Grody, W. W., Mintz, L. E., and Dhanani, S. Tumor necrosis factor-β plays a central role in interleukin-2-induced pulmonary vascular leak and lymphocyte accumulation. Cell. Immunol., 757: 170-180, 1994.